ENDPOINT HEALTH INC
PALO ALTO, CALIFORNIA 943062220
$679K
Total Contract Value
5 awards
First Award
Sep 14, 2022
Last Award
Apr 18, 2024
Business Size
other than small
CAGE Code
8L2B3
Top Industries (NAICS)
| NAICS Code | Obligations | Awards |
|---|---|---|
| 541714 | $679K | 5 |
Contract Awards
1 awards found
75A50122C00058
Department of Health and Human Services
$679K
Sep 14, 2022
ENDPOINT: GENE EXPRESSION SCORING OF IMMUNE ACTIVITY LEVELS FOR PRECISION USE OF HYDROCORTISONE IN SEPTIC SHOCK: SECONDARY ANALYSIS OF THE ADRENAL TRIAL AOI #02: INFECTION SEVERITY AND SOLVING SEPSIS
NAICS: 541714 - RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY)FY2022
Business Details
- UEI
- VXK3H62WKFM1
- CAGE Code
- 8L2B3
- Address
- 401 LAMBERT AVE
PALO ALTO, CA 943062220 - Congressional District
- CA-16
- Phone
- 3104014868
Parent Company
ENDPOINT HEALTH INC
Data Source
This profile is based on federal contract award data from USAspending.gov.
View on USAspending.gov